| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/18/2001 | EP1091978A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 04/18/2001 | EP1091962A1 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 04/18/2001 | EP1091948A2 Tubulin binding compounds (cobra) |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091934A2 Alkyl ketones as potent anti-cancer agents |
| 04/18/2001 | EP1091928A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 04/18/2001 | EP1091924A1 Novel retinoids and use thereof |
| 04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 04/18/2001 | EP1091762A1 Transgene expression in polarized cells |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
| 04/18/2001 | EP1091753A1 Antiproliferative and antiviral proteins and peptides |
| 04/18/2001 | EP1091751A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 04/18/2001 | EP1091745A1 Treatment of hyperproliferative disorders |
| 04/18/2001 | EP1091736A1 Inhibitors of prenyl-protein transferase |
| 04/18/2001 | EP1091734A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0970126B1 Novel method for the production of antihuman antigen receptors and uses thereof |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | EP0874815B1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 04/18/2001 | EP0765321B1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same |
| 04/18/2001 | EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 04/18/2001 | EP0663832B1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291989A Substance having steroid-like structure, process for production thereof and antitumor agents containing same |
| 04/18/2001 | CN1291983A 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 04/18/2001 | CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 04/18/2001 | CN1291974A Cyclohexanediole derivatives |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1291890A 20-Hete antagonists and agonists |
| 04/18/2001 | CN1291886A Formulations |
| 04/18/2001 | CN1291656A Nucleole antigenic monoantibody for esophagus cancer cell, reagent for diagnosing esophagus cancer, and its preparation |
| 04/18/2001 | CN1291615A 2', 3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 04/18/2001 | CN1291511A Natural medicine for resisting cancer transfer |
| 04/18/2001 | CN1291497A Mother liquid medicine for treating liver cancer and its preparing process |
| 04/18/2001 | CN1291482A Chinese medicine for treating cancers and its preparing process |
| 04/18/2001 | CN1291474A Taxusol-lipid composition and its preparing process |
| 04/18/2001 | CN1064676C Ortho-substituted benzoyl guanidine, its preparation, use and medicines containing it |
| 04/18/2001 | CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 04/18/2001 | CN1064543C Tumour eliminating and analgesic adhesive plaster and its preparing process |
| 04/18/2001 | CN1064531C Process for preparation of injectable ready-to use solution containing antitumor anthracycline glycoside |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218425 Useful in the treatment of estrogen-related disorders such as osteoporosis, hyperlipidemia, estrogen-related breast cancer, uterine fibrosis, endometriosis, and restenosis |
| 04/17/2001 | US6218419 Aminoiminoquinone and aminoquinone alkaloid compounds and methods of use |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218401 For therapy of pancreatic tumor cells, lung cancer cells, myeloid leukemia tumor cells, thyroid follicular tumor cells, myelodysplastic tumor cells, epidermal carcinoma tumor cells, bladder carcinoma tumor cells or prostate tumor cells |
| 04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218381 Fused imidazole derivatives as multidrug resistance modulators |
| 04/17/2001 | US6218378 For therapy or inhibition of ovarian tumors, cervical tumors, lung cancer and melanoma |
| 04/17/2001 | US6218377 Methods for the administration of amifostine and related compounds |
| 04/17/2001 | US6218375 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin and method |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218369 Administering flavanolignane selected from silymarin, silybin, silidianin, silicristin, dehydrosilybin, phospholipid complex of one of these flavanolignanes, and mixtures, in combination with antitumor agent |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6218180 Virion coding a toxic agent, cytokine and tumor suppressor; for the treatment of tumorous defects; antitumor agents |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6217895 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 04/17/2001 | US6217881 Vaccine |
| 04/17/2001 | US6217869 Administering antibody, antigen, ligand complex |
| 04/17/2001 | US6217866 Antitumor agents mixture |
| 04/17/2001 | US6217864 Method for targeted degradation of intracellular proteins in vivo or ex vivo |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/17/2001 | CA2071483C Oligonucleotide analogs with novel linkages |
| 04/17/2001 | CA2055493C Antineoplastic solution and method for treating neoplasms |
| 04/17/2001 | CA2024255C A novel pharmaceutical composition having antitumor activity and preparation for its manufacture |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025441A2 Tumour-specific vector for gene therapy |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025422A2 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 04/12/2001 | WO2001025410A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 04/12/2001 | WO2001025408A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | WO2001025399A2 Non-invasive tumor imaging by tumor-targeted bacteria |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025275A1 Regulatory/unfolding peptides of ezrin |
| 04/12/2001 | WO2001025273A2 Compositions and methods for wt1 specific immunotherapy |
| 04/12/2001 | WO2001025271A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025266A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |